Imatinib interim therapy between chemotherapeutic cycles and in vivo purging prior to autologous stem cell transplantation, followed by maintenance therapy is a feasible treatment strategy in Philadelphia chromosome-positive acute lymphoblastic leukemia

Bone Marrow Transplant. 2005 Nov;36(10):917-8. doi: 10.1038/sj.bmt.1705144.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Benzamides
  • Bone Marrow Purging / methods*
  • Female
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Imatinib Mesylate
  • Neoplasm, Residual / diagnosis
  • Neoplasm, Residual / drug therapy
  • Piperazines / therapeutic use*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
  • Pyrimidines / therapeutic use*
  • Transplantation, Autologous

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate